Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 16/20 | 0.45 |
| ▸ | CNR2 | P34972 | 14/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6776468 | 0.92 | CNR1 (0.46) | CNR1CNR2 | |
| SCHEMBL6769424 | 0.91 | CNR1 (0.46) | CNR1CNR2 | |
| SCHEMBL6769589 | 0.89 | CNR1 (0.47) | CNR1CNR2 | |
| SCHEMBL5769254 | 0.89 | CNR1 (0.45) | CNR1CNR2 | |
| SCHEMBL6770766 | 0.89 | CNR1 (0.45) | CNR1CNR2 | |
| SCHEMBL6768958 | 0.87 | CNR1 (0.45) | CNR1CNR2 | |
| SCHEMBL6765994 | 0.82 | CNR1 (0.48) | CNR1CNR2LMNA | |
| SCHEMBL6770110 | 0.82 | CNR1 (0.50) | CNR1CNR2 | |
| SCHEMBL5768210 | 0.81 | CNR1 (0.47) | CNR1CNR2 | |
| SCHEMBL5770166 | 0.81 | CNR1 (0.53) | CNR1CNR2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040235926-A1 | Cannabinoid receptor ligands and uses thereof | PFIZER INC. | 2004-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040235926-A1 | Cannabinoid receptor ligands and uses thereof | CNR1, CNR2, GPR18 | CNR1 1/4885CNR2 2/4885LMNA 3194/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.